Recent neuropsychological studies in healthy volunteers suggest that antidepressants enhance the processing of positive emotional information. However, the neural substrates underpinning these changes have not been fully elucidated. The current study, therefore, used functional magnetic resonance imaging (fMRI) to map brain systems activated during successful categorization and subsequent recognition of self-referent positive and negative personality characteristics in healthy volunteers following short-term (7 days) repeated administration of the selective noradrenergic reuptake inhibitor reboxetine. Twenty-four healthy volunteers were randomly assigned to 7-day double-blind intervention with reboxetine or placebo. On day 7, neural responses during the categorization and subsequent recognition of positive and negative characteristics were assessed using fMRI. Questionnaires monitoring mood, hostility and anxiety were given before and during this intervention. During categorization, reboxetine was associated with greater activation to positive words, relative to negative words, in left precuneus and right inferior frontal gyrus. By contrast, at subsequent recognition reboxetine was associated with reduced response to positive words, relative to negative words, in left precuneus, anterior cingulate and medial frontal gyrus. These changes in the neural processing of positive and negative words occurred in the absence of significant differences in ratings of mood and anxiety. Such adaptations in the neural processing of emotional information support the hypothesis that antidepressants have early effects on emotional processing in a manner which would be expected to reverse negative biases in depression.
Introduction
Depression has been associated with a number of cognitive correlates; for instance, depressed individuals typically show impaired recall for positive material and enhanced recall for negative information. 1 Such observations are consistent with cognitive theories of depression which suggest that a negative emotional bias may be important in the aetiology and maintenance of depression, 2 with Cognitive Behavioural Therapy (CBT) explicitly seeking to reverse this negative bias. 3 Although there has been little interface between pharmacological and cognitive theories of depression to date, recent behavioural data suggest that antidepressant administration modulates emotional processing in a manner consistent with these cognitive theories of depression. For example, we have demonstrated that short-term (7 days) administration of the highly selective noradrenaline reuptake inhibitor (selective NRI) reboxetine significantly facilitated speed to categorize positive vs negative personality characteristics processed in a self-referential fashion in healthy volunteers. 4 Moreover, reboxetine increased delayed free recall of these positive trait words as compared to negative words. This increased positive emotional processing was also seen following a single dose of reboxetine. 5 In both studies, 4, 5 changes in emotional processing occurred in the absence of significant differences in subjective mood and occurred more rapidly than the full therapeutic effects of antidepressants would be expected to occur in depression. 6 Hence, antidepressants may alter the neural processing of emotional information prior to more formal changes in mood and subjective state. Such changes in the relative processing of positive and negative self-referent emotional information could be an important factor in the mechanism of action of antidepressant therapy, which is consistent with cognitive theories of depression. A greater understanding of the neural substrates that underlie these behavioural changes would undoubtedly facilitate the integration of pharmacological and cognitive theories of depression.
Identification of the neural substrates underlying emotional processing is an expanding area of research. Recent functional magnetic resonance imaging (fMRI) [7] [8] [9] [10] and Positron Emission Tomography (PET) 11 studies have identified medial prefrontal (MPFC), parietal and occipital cortex as part of an extended network of brain regions involved in the categorization and recognition of positive and negative personality-trait words processed in a selfreferential manner. For example, increased blood oxygenation level-dependent (BOLD) activity in parietal and occipital regions has been hypothesized to reflect enhanced attentional processes to biologically significant or personally relevant events. 12 In addition, previous work has noted the involvement of the MPFC, premotor, dorsolateral prefrontal cortex and precuneus during tasks that require self reference. 7, 8, 10, 13 Activation in these regions during selfreferential processing may reflect a number of cognitive processes including attention, elaboration, rehearsal and appraisal/evaluation of emotion 14 processes that are targeted in psychotherapy to guide self regulation of emotional experience. 7 Successful recognition of self-encoded personality-trait words has also been shown to reactivate right MPFC, as well as lateral prefrontal, premotor, parietal, anterior cingulate cortex and precuneus. 8 However, the precise function of MPFC during self-referential processing remains unclear. For example, in a recent fMRI study, Moran et al. 10 demonstrated that distinct neural circuits within prefrontal cortex subserve the cognitive and emotional aspects of self-referential processing of personality-trait words. The cognitive component of the task (that is 'like me/not like me') engaged the MPFC irrespective of the valence of the trait word, whereas the affective component of the task (that is 'favourable/unfavourable') was resolved in ventral anterior cingulate cortex. 10 Taken together, 7, 8, 10 the above findings implicate medial frontal, cingulate, parietal cortex and precuneus in tasks that require self-referential processing of personality-trait words.
In line with the importance of the above neural systems in self-referential processing, we recently demonstrated that a single dose of reboxetine affected BOLD responses within a similar network during emotional memory retrieval in healthy volunteers. 15 In particular, reboxetine enhanced the behavioural efficiency of positive words during retrieval, and reduced BOLD response during correct recognition of positive personality-trait words in frontal and parietal cortex. These data are also consistent with our earlier behavioural studies 4, 5 that demonstrated enhanced memory for positive personality-trait words and suggest that such retrieval is associated with reduced cognitive load. However, both clinical and healthy volunteer studies suggest that acute antidepressant drug administration can have different effects from repeated administration and it is unclear whether these acute actions are relevant to therapeutic courses of antidepressant drug administration. Recent metaanalysis suggests that positive effects of antidepressants on clinical symptoms can be seen as early as one week after treatment initiation. 16 The current study, therefore, aimed to investigate the effects of shortterm reboxetine (7 days) upon emotional categorization and successful recognition of emotional items processed in a self-referential manner using a rapid event-related fMRI design. Based on the findings from our earlier behavioural studies 4, 5 and fMRI studies 14 we wished to test the following specific predictions:
(1) Reboxetine would increase BOLD response in frontal (right MPFC/ventral anterior cingulate cortex) and precuneus during categorization of positive vs negative personality-trait words; and (2) Reboxetine would decrease BOLD response in frontal (right MPFC and anterior cingulate cortex) and precuneus during recognition of positive vs negative personality-trait words.
Materials and methods

Participants
Twenty-four right-handed healthy volunteers (12 males, age range 18-41 years) were recruited by advertisement. All subjects provided written informed consent prior to entry into the study, which was approved by the Oxford Research Ethics Committee, and received an honorarium for their participation. From assessment with the Structured Clinical Interview for DSM-IV, 17 subjects were determined to be free of current or past axis-1 disorder (including anxiety disorders, depression, eating disorder, psychosis and substance abuse). All subjects were in good physical health and free of current medication. The premenstrual week was avoided for the study period in female subjects. Subjects were briefed on scanner safety and had no contraindications for fMRI examination.
Experimental design
The study was a double-blind, randomized, placebocontrolled between-groups design. Subjects were randomly allocated to receive either reboxetine (4 mg b.i.d.) or placebo for a total of 7 days. Medication was given in identical capsules to maintain blinding. The two groups were matched in terms of gender (6 Subjective state was recorded each day of the study using the Beflindlichkeits scale (BFS) of mood and energy 19 and the Positive Affect and Negative Affect Scales (PANAS) 20 to provide sensitive measures of day-by-day variation in mood. 19 In addition the following questionnaires were given before and on the seventh day of intervention: State-Trait Anxiety Inventory (STAI), 21 Buss-Durkee Hostility Inventory (B-DHI), 22 Beck Depression Inventory (BDI) 23 and the Social Adaptation Self-evaluation Scale (SASS). 24 Verbal stimuli For the emotional categorization task two lists of 60 personality-trait adjectives were constructed from Anderson's list of personality-trait words. 25 Within each of the lists half of the words were unambiguously positive and half were negative. Positive and negative words were matched on length, written frequency 26 and meaningfulness. 25 Subjects were not explicitly instructed to remember the words. In addition, each list contained 20 control words (10 presentations each of 'left' and 'right') included as a baseline control condition (n.b. baseline comparisons were not included in the current report, please see 'Limitations' in the 'Discussion' section for issues relating to baseline measures in pharmacological fMRI studies). Thus, 160 words were presented in total across two scanning runs. The words 'left' and 'right' were selected in order to control for the sensorimotor aspects of the task without requiring subjective assessment of the positive or negative aspects of the word. Each positive and negative word occurred in only one of the lists. Order of presentation of lists was counterbalanced across groups and word order within each list was randomized.
For the incidental emotional memory task the previously encoded words (old words) were randomized to two lists and mixed with 60 positive and 60 negative distracters (new words) taken from Anderson's list. 25 There were an equal number of new and old words in each list, new words were unambiguously positive or negative and matched to the old words on length, written frequency 26 and meaningfulness. 25 Thus, 240 words were presented in total across two scanning runs. Order of presentation of lists was counterbalanced across groups and word order within each list was randomized. In order to allow a direct comparison between the current study and our earlier fMRI study following an acute dose of reboxetine (which included 60 words at categorization and 120 words at recognition 15 ) we report on the findings from run 1 only.
Task design fMRI scans were acquired while subjects performed both the emotional categorization and recognition tasks. We will refer to these as the categorization and recognition conditions, respectively. Stimuli were presented on a personal computer using E-Prime (version 1.0; Psychology Software Tools Inc., Pittsburgh, PA, USA) and projected onto an opaque screen at the foot of the scanner bore, which subjects viewed using angled mirrors.
During the categorization condition subjects were instructed to, as quickly and as accurately as possible, characterize the words as likeable or dislikeable in a self-referential fashion. Specifically, subjects were asked to imagine whether they would be pleased or upset if they overheard someone else referring to them as possessing this characteristic, so that the judgement was in part self referring. Thus, each word prompted a 'likeable' or 'dislikeable' response and subjects pressed a button with the right index or middle finger, respectively, to indicate their decision. For the baseline control words 'left' and 'right', subjects responded with their right index or middle finger, respectively. Subject responses were recorded using an MRI-compatible keypad. Both accuracy and reaction times were recorded by E-Prime. Each trial consisted of a fixation cross displayed for 500 ms immediately followed by a personality-trait or control word displayed for 500 ms. The duration of the intertrial interval (ITI) varied between 4000 and 8000 ms according to a Poisson distribution, with a mean ITI of 5000 ms. The total duration of each run was therefore 6.7 min.
Emotional categorization was immediately followed by an unexpected recognition task. For the recognition condition, subjects were instructed to discriminate between studied (old) words and unstudied (new) words. Each word prompted a 'yes' (old) or 'no' (new) response and subjects pressed a button with the right index or middle finger, respectively, to indicate their decision. Trial presentation was identical to that during the categorization condition. The total duration of each run was therefore 10 min.
Visual stimulation paradigm
The recognition task was followed by a simple visual stimulation task. Alternating chequerboard stimuli (frequency = 8 Hz) were visually presented in a block design with 15-s blocks of stimulation alternating periodically with 15-s blocks of a stationary fixation cross. A total of 20 cycles of visual stimulation/ fixation was presented in the course of an experiment lasting 5 min in total. Subjects were instructed to lie quietly with their eyes open throughout the experiment. Due to time constraints, data from one subject (reboxetine treated) were not acquired; subsequent analysis of this experiment, therefore, includes data from 12 placebo controls and 11 reboxetine treated subjects.
fMRI data acquisition All imaging data were collected using a 1.5T Siemens Sonata scanner located at the Oxford Centre for Clinical Magnetic Resonance Research (OCMR). Functional imaging consisted of 35 T 2 *-weighted echo-planar image (EPI) slices (repetition time (TR) = 3000 ms, echo time (TE) = 50 ms, matrix = 64 Â 64), 3 mm isotropic voxels. To facilitate later coregistration of the fMRI data into standard space, we also acquired a Turbo FLASH sequence (TR = 12 ms, TE = 5.65 ms) voxel size = 1 mm 3 . The first two EPI volumes in each session were discarded to avoid T 1 equilibration effects.
fMRI data analyses Functional MRI data were preprocessed and analysed using FSL (version 3.2, www.fmrib.ox.ac.uk/fsl). 27 Preprocessing included slice acquisition time
The effects of reboxetine on emotional processing R Norbury et al correction using Fourier-space time-series phase-shifting, within-subject image realignment, 28 non-brain removal 29 spatial normalisation to a standard template (Montreal Neurological Institute (MNI) 152 stereotactic template) using an affine procedure 30 and spatial smoothing using a Gaussian kernel (5 mm full-width-half-maximum). The time series in each session was high-pass filtered (to a maximum of 0.025 Hz).
Analyses of data from individual subjects were computed using the general linear model with local autocorrelation correction. 31 For the categorization task three explanatory variables were modelled: 'negative', 'positive' and 'control' words. For the recognition condition two explanatory variables were modelled: 'positive remembered' and 'negative remembered'. In addition, temporal derivatives were included in the model as covariates of no interest to increase statistical sensitivity. All variables were modelled by convolving the onset of each word with a haemodynamic response function, using a variant of a gamma function (that is a normalisation of the probability density function of the gamma function) with a standard deviation of 3 s and a mean lag of 6 s.
Individual subject's data were combined at the group level using a mixed effects analyses. 32 This mixed effects approach enables generalization of the results beyond the sample of subjects tested. In a whole brain analysis, significant activations were identified using cluster-based thresholding of statistical images with a height threshold of Z > 2.3 and a (corrected) spatial extent threshold of P < 0.05. 33 Given the findings from earlier neuroimaging studies implicating the right MPFC and vACC, 7, 8, 10 regions of interest (right MPFC, 8 mm sphere; and vACC, 12 mm sphere) were generated based on the coordinates described by Moran et al. 10 Approximate Brodmann's Areas (BA) were identified by transformation of MNI coordinates into Talairach space. 34 (Additional information available at http://www.mrc-cbu.cam.ac.uk/ Imaging.) fMRI comparisons For the categorization task we contrasted whole brain responses to correctly categorized positive vs negative words. For the recognition task, across the whole brain, we contrasted correctly remembered positive words with correctly remembered negative words. For those regions where a significant drug by task interaction was identified, per cent BOLD signal change for each contrast was calculated in order to identify the profile of drug effect.
Behavioural data analysis Behavioural data were analysed using a repeated measures analysis of variance (ANOVA) model with group as the between-subject factor and valence as the within-subjects factor implemented in SPSS v.12.0 (SPSS Inc., Chicago, IL, USA). Significant interactions were followed up using simple main effects analyses. Accuracy of recognition was indexed by the discrimination accuracy measure A 035 (A 0 typically ranges from 0.5, which indicates signals cannot be distinguished from noise, to 1 which corresponds to perfect performance). Recognition accuracy was calculated separately for positive and negative stimuli and analysed using both one-sample (to assess withingroup accuracy) and repeated measures ANOVA (to assess between-group accuracy).
Results
Behavioural results
Subjective state ratings. One subject in the placebo group did not complete the SASS and one subject in the reboxetine group did not fully complete the B-DHI on day 7. Subsequent analyses of these measures, therefore, include 11 placebo treated volunteers (SASS) and 11 Reboxetine treated volunteers (B-DHI). We found no main effect of group, time or group-by-time interactions on the BDI, PANAS, trait and state anxiety (STAI) B-DHI or the BFS mood scale (P > 0.05 for all comparisons). For the BFS energy scale there was no significant main effect of group or time. We did, however, observe a significant groupby-time interaction (F(1,22) = 6.72, P = 0.017). Post hoc analyses revealed that this was due to the reboxetine group endorsing fewer descriptions of low energy after treatment (independent measures; before treatment, t 22 = 1.36, P = 0.188; after treatment, t 22 = À2.173, P = 0.04).
Categorization and recognition. Reboxetine did not affect accuracy or response time to correctly categorized positive and negative words (all P's > 0.05) ( Table 1 ). Accuracy of recognition (A 0 ) for correctly recognized positive and negative words was significantly greater than 0.5 for both groups (one sample t-test, both P's < 0.05). Reboxetine, however, did not affect accuracy or response time for correctly recognized emotional words (see Table 1 ). Thus, differences in neural responses can be explored in the absence of significant between-group differences in overall mood or behavioural performance during fMRI.
fMRI results: emotional categorization Does short-term administration of reboxetine in healthy volunteers modulate neural processing during the categorization of positive and negative personality-trait words?
We observed significant group Â word type interactions in precuneus (BA 31, x = À10, y = À68, z = 24, F(1,22) = 46.88, P = < 0.001) (Figures 1 and 2 ) and right inferior frontal gyrus (BA 44, x = 56, y = 2, z = 4, F(1,22) = 13.77, P = 0.001). Post hoc analysis showed that in precuneus BOLD response (as percentage signal change) to negative words was greater under placebo (t(22) = 2.46, P = 0.024), but reboxetine was associated with significantly greater activation to positive words (t(22) = À3.879, P < 0.001). In the right inferior frontal gyrus cluster, the significant interaction was driven again by both greater BOLD response
The effects of reboxetine on emotional processing R Norbury et al to negative words (t(22) = 2.08, P = 0.049) and decreased BOLD response to positive words (t(22) = À1.87, P = 0.075) following placebo compared to reboxetine, although both comparisons were of trend-level significance. All interactions (including the whole brain analysis) remained significant with the removal of outliers identified in Figures 1 and 2 (outliers were defined as points > 1.5 times the interquartile range from the upper/lower limit of the interquartile range). There was no significant groupemotion interaction in vACC or right MPFC. However, consistent with Fossati et al. (2003), 7 there was a significant main effect of emotion (F(1,22) = 5.12, P = 0.034) such that both placebo and reboxetine treated volunteers showed greater response to positive words (Table 2) .
fMRI results: recognition Does short-term administration of reboxetine in healthy volunteers modulate neural processing during recognition of positive and negative personalitytrait words?
Significant group Â word type interactions were observed in (see The effects of reboxetine on emotional processing R Norbury et al Post hoc analysis showed that in medial frontal gyrus BOLD response (as percentage signal change) to negative words was significantly greater under reboxetine (t(22) = À3.79, P = 0.001). For positive words, in the same brain region, there was a trend towards reduced BOLD response under reboxetine (t(22) = 1.82, P = 0.082). In cingulate gyrus we observed significantly greater activation to negative words under reboxetine (t(22) = À3.37, P = 0.003). For positive words in the same brain region, we found significantly reduced BOLD response under reboxetine (t(22) = 2.76, P = 0.012). In precuneus, we observed greater activation to negative words under reboxetine t(22) = À3.63, P = 0.001, but a similar response between groups to positive words. All interactions (including the whole brain analysis) remained significant with the removal of outliers. There was no significant main effect of emotion or group Â emotion interaction in vACC. In right MPFC there was no significant group Â emotion interaction, both groups showed greater activation to positive personality-trait words, compared to negative words but this main effect was not significant (F < 1) ( Table 3) .
Visual stimulation control experiment. A region of occipital (calcarine) cortex activated by photic stimulation across all subjects was identified as a region of interest. There were no significant effects of group (thresholded at Z > 2.3, P < 0.05, corrected) to photic stimulation in this region of occipital cortex.
Discussion
The current study demonstrated that short-term (7 day) repeated administration of the antidepressant reboxetine modulates neural processing of emotional information in healthy volunteers. During categorization of personality-trait words, reboxetine was associated with increased activation to positive words, relative to negative words, in inferior frontal gyrus and precuneus. By contrast, at subsequent recognition a reversal of this pattern was observed; reboxetine treated volunteers showed reduced BOLD response in medial frontal and cingulate gyrus as well as precuneus during successful recognition of positive vs negative personality-trait words. The pattern of changes reported here are consistent with the behavioural and neural effects of reboxetine previously reported. 4, 5, 14 Reboxetine and emotional categorization Our earlier behavioural studies 4, 5 have demonstrated that reboxetine biases categorization in a positive manner shortly after administration. In these studies 4,5 both acute and 7-day administration of reboxetine, compared to placebo control, was associated with reduced latency to categorize positive personality-trait words relative to negative words. One interpretation of the present findings of significantly increased BOLD response in precuneus and in right inferior frontal cortex to positive words, and those of our earlier behavioural studies, is that reboxetine is associated with enhanced salience of positive stimuli. Consistent with this hypothesis, others have suggested that during self-referential processing of negative personality-trait words activity in precuneus is related to increased resource recruitment. 7 In a more recent study, Ofek et al. 36 reported greater precuneus and frontal cortex activity (as measured by event-related potentials (ERP)) to positive and negative words that subjects rated as having greater individual significance. Taken together these results suggest that reboxetine is able to reverse the normal pattern of activity in precuneus during the selfreferential processing of negative vs positive words; consistent with greater subjective significance and attentional processing of positive descriptors following reboxetine.
Consistent with Fossati et al. 7 we observed greater activation to positive, compared to negative words, in right MPFC. However, there was no significant group Â emotion interaction in right MPFC or vACC. Our experimental design was powered to directly examine the neural processing of positive and negative personality-trait words processed in a self-referential manner, we did not include a non-self-referential processing condition (that is semantic judgement 7 ) nor did we ask subjects to rate the valence of the words. 10 Future studies that incorporate self and Regions of increased activation under reboxetine for the orthogonal contrast positive personality-trait words vs negative words. a Coordinates refer to the position (x, y and z mm) for the peak voxel in each cluster according to the MNI template.
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Reboxetine and subsequent recognition
We have previously demonstrated that both acute and 7-day administration with reboxetine facilitates memory for positive self-personality-trait words. 4, 5 In addition, using event-related fMRI, 15 we have shown that acute administration of reboxetine is associated with reduced BOLD response during correct recognition of positive personality-trait words. These earlier findings 4, 5, 15 are remarkably consistent with those reported here and suggest that similar antidepressant drug effects are seen following acute and repeated administration in healthy volunteers. Such a reduction in frontal and cingulate cortex and precuneus response during the retrieval of positive vs negative adjectives following reboxetine may reflect reduced retrieval effort for these words. Indeed, if our hypothesis that at categorization reboxetine weights positive personality-trait words as subjectively more significant, and thereby enhances memory formation, subsequent retrieval of these items would be cognitively less demanding. In further support of this hypothesis, a number of earlier neuroimaging studies of episodic and working memory report that increased cognitive effort at retrieval is associated with increased BOLD response. 37, 38 A week's treatment with reboxetine decreased activation during recognition of positive vs negative personality-trait words in an area of the right medial frontal cortex (BA 6) similar to acute administration of reboxetine seen previously 15 (MNI coordinates x = 10, y = À10, z = 62 (current report), MNI coordinates x = 20, y = À14, z = 60 (single-dose reboxetine study)). Engagement of right medial frontal cortex (BA6) during memory retrieval has been previously reported 39 and is suggested to be greater during recognition compared to recall tasks. 40 Greater activation in right medial frontal cortex (BA 6) during retrieval of self-referentially processed personalitytrait words has also been reported. 8 The above findings, therefore, implicate right medial frontal cortex in episodic retrieval and memory for selfreferentially processed personality-trait words. Moreover, the current report and the results from our earlier fMRI study 15 suggest that activation in this region is modulated by antidepressant administration.
During correct recognition of personality-trait words reboxetine was associated with decreased activation to positive vs negative words in anterior cingulate cortex (BA 24, x = À10, y = 0, z = 46). Converging evidence from PET and fMRI studies [41] [42] [43] have implicated this more dorsal/posterior region of the anterior cingulate, adjacent to the frontal limbic area, as playing a pivotal role in effortful attentional processes and conflict monitoring. These earlier findings are consistent with our hypothesis that effortful processing is reduced during the retrieval of positive words following reboxetine treatment. Although we did not see any behavioural differences in recognition here, previous studies have reported decreased latency to recognize positive words and increased free recall of these negative stimuli following reboxetine consistent with this interpretation.
We also observed reduced activation to positive vs negative personality-trait words under reboxetine in precuneus. Precuneus is one of the regions most frequently activated during episodic retrieval tasks, 44 however the role of this region remains unclear. One hypothesis is that the role of precuneus in memory retrieval is that of visual imagery, a suggestion supported by neuroimaging evidence that precuneus activation is greater during retrieval of imageable vs non-imageable words. 45 It is possible, therefore, that the increased activation to negative words seen in precuneus under reboxetine reflects the requirement for more elaborative recognition processes, perhaps including greater or longer lasting visual representation of these negative stimuli.
Limitations
Characterizing the effects of reboxetine (or any drug) upon task-specific brain activity may be confounded by drug-related effects on baseline activity. Thus, some drug-related effects on BOLD signal may be a neuronally non-specific consequence of altered cerebral haemodynamics. 46 Arguing against this interpretation of our data, there was no significant effect of reboxetine on BOLD signal in primary visual cortex, indicating a degree of region and task specificity unlikely to be related to global effects of reboxetine on baseline blood flow or neuronal coupling. In addition, the double dissociation in the effects of reboxetine on positive vs negative responses argues against these results as being interpreted in terms of non-specific perfusion differences.
In contrast to our previous studies, we did not observe any significant differences in behavioural categorization or recognition performance. BOLD responses within these networks may be more sensitive to drug effects than behavioural outputs, which rely on the summation of a number of cognitive operations. In addition, indexing subtle metrics, such as response time, in the scanning environment is challenging. Subjects are positioned supine on the scanner gantry, stimuli are viewed via angled mirrors (or equivalent set-up) and processed in the presence of background noise. Future studies may benefit from the use of an immediate free recall task prior to acquiring the recognition component to provide an index of behavioural differences between the two groups.
Modelling antidepressant mechanisms in healthy volunteers
Modelling the effects of antidepressants in healthy non-depressed subjects ensures that behavioural/ neural differences can be explored unconfounded by changes in symptom state. In addition, well-designed
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Summary
In summary, we have demonstrated that, even in the absence of measurable differences in subjective mood, short-term repeated administration of the antidepressant reboxetine affects the neural processing of emotional information in healthy volunteers. At categorization, reboxetine increased BOLD response to positive personality-trait words, relative to negative words, in precuneus and inferior frontal gyrus. At subsequent recognition, reboxetine was associated with decreased activation to positive words, relative to negative words, in medial frontal, cingulate gyrus and precuneus. The current data are consistent with the behavioural and neural effects of reboxetine previously reported 4, 5, 15 and provide further support for the hypothesis that antidepressants rapidly bias processing towards positively valenced emotional material and may therefore act in a manner compatible with cognitive-behavioural theories of depression. It is widely held that significant antidepressant treatment effects are not reliably demonstrated until after several weeks of treatment. However, the results from a recent meta-analysis 16 (which has the advantage of pooling results from a large number of well designed placebo controlled studies) suggest that antidepressant treatment is associated with significant symptomatic improvement by the end of the first week of use. It is tempting to speculate that the rapid, antidepressant-induced, positive bias reported here, and in our earlier behavioural 4, 5 and fMRI studies 15 is an important component of early antidepressant action. The self-referential paradigm used here provides a useful tool for modelling the effects of antidepressants on emotional processing and could be readily adapted for use in a clinical setting.
